» Authors » H L Tillmann

H L Tillmann

Explore the profile of H L Tillmann including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 96
Citations 1035
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dirks M, Pflugrad H, Haag K, Tillmann H, Wedemeyer H, Arvanitis D, et al.
J Viral Hepat . 2017 Jan; 24(7):541-550. PMID: 28117537
One of the most disabling symptoms of hepatitis C virus (HCV) infection is chronic fatigue. While this is accepted for HCV polymerase chain reaction (PCR)-positive patients, a relationship between HCV...
2.
Weissenborn K, Tillmann H
J Viral Hepat . 2016 May; 23(8):580-3. PMID: 27225063
Anti-HCV positive individuals frequently complain about chronic disabling fatigue, mood alterations and deficits in concentration and memory. Several data provide evidence that such alterations are unrelated to hepatitis C virus...
3.
Patel K, Tillmann H, Matta B, Sheridan M, Gardner S, Shackel N, et al.
Aliment Pharmacol Ther . 2015 Nov; 43(3):356-63. PMID: 26560052
Background: Assessment of fibrosis progression in chronic liver disease relies upon non-invasive tools and changes in semi-quantitative histopathology scores that may not be reliable. Aim: To assess the diagnostic performance...
4.
Wiegand J, Wedemeyer H, Franke A, Rossler S, Zeuzem S, Teuber G, et al.
J Viral Hepat . 2013 Dec; 21(10):744-50. PMID: 24329913
Acute hepatitis B virus (aHBV) infection can lead to fulminant liver failure, which likely is prevented by early lamivudine therapy. Even nonfulminant but severe acute hepatitis B can lead to...
5.
Ernst D, Greer M, Akmatova R, Pischke S, Wedemeyer H, Heiken H, et al.
HIV Med . 2013 Oct; 15(4):245-50. PMID: 24118889
Objectives: The impact of coexisting GB virus C (GBV-C) infection on the clinical course of HIV infection remains controversial. Early data from HIV-1 infected patients attending the Hannover Medical School...
6.
Rifai K, Hadem J, Wiegand J, Potthoff A, Pischke S, Klempnauer J, et al.
Z Gastroenterol . 2012 Aug; 50(8):760-5. PMID: 22895904
Introduction: The course of viral hepatitis shows wide interindividual differences, ranging from asymptomatic disease to liver failure. Only limited data on gender differences in patients undergoing liver transplantation (OLT) exist....
7.
Wiegand J, Kuhne M, Pradat P, Mossner J, Trepo C, Tillmann H
Aliment Pharmacol Ther . 2012 Apr; 35(12):1443-50. PMID: 22530565
Background: The histological pattern of fibrosis in liver cirrhosis varies in different chronic liver diseases, and hepatic decompensation may be differentiated in consequences of fibrosis (i.e. ascites, variceal bleeding) or...
8.
Clark P, Thompson A, Zhu M, Vock D, Zhu Q, Ge D, et al.
J Viral Hepat . 2012 Apr; 19(5):332-40. PMID: 22497812
Low-density lipoprotein cholesterol (LDL-C) levels and interleukin 28B (IL28B) polymorphism are associated with sustained viral response (SVR) to peginterferon/ribavirin (pegIFN/RBV) for chronic hepatitis C (CHC) infection. IL28B has been linked...
9.
Jazwinski A, Thompson A, Clark P, Naggie S, Tillmann H, Patel K
J Viral Hepat . 2012 Mar; 19(4):278-82. PMID: 22404726
Cytokeratin-18 (CK-18) is a major intermediate filament protein in liver cells. The M30 fragment of CK-18 has been identified as a useful marker of apoptosis associated with fibrosis and steatosis...
10.
Veldt B, Duarte-Rojo A, Thompson A, Watt K, Heimbach J, Tillmann H, et al.
Am J Transplant . 2012 Feb; 12(3):737-44. PMID: 22300408
IL28B polymorphisms are strongly associated with response to treatment for HCV infection. IL28B acts on interferon-stimulated genes via the JAK-STAT pathway, which has been implicated in development of insulin resistance....